MobileODT
Tel Aviv
About MobileODT
MobileODT builds small, smart, connected visual diagnostic tools to enable any health provider, anywhere, to conduct examinations on the level of an expert practitioner. Empowering less-trained providers increases the reach of health systems, reducing costs, and improving outcomes. The Enhanced Visual Assessment (EVA) System is our first product, an FDA cleared internet-connected mobile colposcope and is growing rapidly in market share in the US, across Africa, and India. It is used in the world’s harshest environments and receives accolades from clinicians in the world’s leading hospitals (MD Anderson, Mount Sinai, Apollo). EVA has been used for over 40,000 procedures in 29 countries. Our customers include the world’s leading hospital groups West and East, and our fastest-growing market is the US, where we are becoming the standard for visualization (+20% of hospitals in New York State who offer Sexual Assault Forensic Examinations use EVA). We are growing rapidly in new geographies and have in the pipeline additional visual-based applications, including ENT, Oral disease, and Skin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $14.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2020)
- Website: mobileodt.com
- Phone: +972 52-432-7686
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/mobileodt-12352 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.